跳至主要内容
临床试验/NCT00653562
NCT00653562已完成4 期

Single Blind, Multi-center, Post Marketing Clinical Study of Zolpidem (Myslee) in Adolescent Patients With Insomnia - Evaluation With Polysomnography

Astellas Pharma Inc0 个研究点目标入组 11 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
11
主要终点
Sleep latency

研究概览

简要总结

To evaluate the efficacy of zolpidem for adolescent insomniacs with polysomnography

详细描述

The study consists of two parts. All patients will receive placebo in one part and Zolpidem in the other part in a single blind manner. Efficacy will be measured with polysomnography .

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10

排除标准

  • Patients with schizophrenia or manic-depressive illness
  • Patients with insomnia caused by physical diseases
  • Patients having a history of hypersensitivity to zolpidem
  • Patients with attention-deficit hyperactivity disorder

研究组 & 干预措施

1

Experimental

Patients will receive placebo in one part and zolpidem in the other part

干预措施: zolpidem (Drug)

结局指标

主要结局

Sleep latency

时间窗: 2 days

次要结局

  • Time of intermediate awaking(2 days)
  • Patient impression(2 days)
  • Total hours of sleep(2 days)
  • Frequency of intermediate awaking(2 days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Zolpidem (Myslee) Post Marketing Study in Adolescent... | 临床试验